- Home
- ATAI vs VXRT Comparison
ATAI vs VXRT Comparison
Compare ATAI & VXRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATAI
- VXRT
- Stock Information
- Founded
- ATAI 2018
- VXRT N/A
- Country
- ATAI Germany
- VXRT United States
- Employees
- ATAI N/A
- VXRT N/A
- Industry
- ATAI Biotechnology: Pharmaceutical Preparations
- VXRT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ATAI Health Care
- VXRT Health Care
- Exchange
- ATAI Nasdaq
- VXRT Nasdaq
- Market Cap
- ATAI 214.8M
- VXRT 200.3M
- IPO Year
- ATAI 2021
- VXRT N/A
- Fundamental
- Price
- ATAI $1.59
- VXRT $0.61
- Analyst Decision
- ATAI Strong Buy
- VXRT Strong Buy
- Analyst Count
- ATAI 4
- VXRT 2
- Target Price
- ATAI $9.00
- VXRT $3.00
- AVG Volume (30 Days)
- ATAI 2.2M
- VXRT 1.5M
- Earning Date
- ATAI 11-13-2024
- VXRT 11-13-2024
- Dividend Yield
- ATAI N/A
- VXRT N/A
- EPS Growth
- ATAI N/A
- VXRT N/A
- EPS
- ATAI N/A
- VXRT N/A
- Revenue
- ATAI $331,000.00
- VXRT $16,760,000.00
- Revenue This Year
- ATAI $44.72
- VXRT $67.95
- Revenue Next Year
- ATAI N/A
- VXRT N/A
- P/E Ratio
- ATAI N/A
- VXRT N/A
- Revenue Growth
- ATAI N/A
- VXRT 303.27
- 52 Week Low
- ATAI $1.03
- VXRT $0.52
- 52 Week High
- ATAI $2.85
- VXRT $1.54
- Technical
- Relative Strength Index (RSI)
- ATAI 61.56
- VXRT 32.15
- Support Level
- ATAI $1.53
- VXRT $0.67
- Resistance Level
- ATAI $1.95
- VXRT $0.65
- Average True Range (ATR)
- ATAI 0.20
- VXRT 0.05
- MACD
- ATAI 0.04
- VXRT -0.01
- Stochastic Oscillator
- ATAI 60.00
- VXRT 12.64
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.
About VXRT Vaxart Inc
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.